CELLBXHEALTH PLC – Parsortix Ctcs Used For Brain Cancer Detection
RNS Number : 9615P CelLBxHealth PLC 11 August 2026 CelLBxHealth plc (“CelLBxHealth” or “the Company”) Parsortix CTCs used
RNS Number : 9615P CelLBxHealth PLC 11 August 2026 CelLBxHealth plc (“CelLBxHealth” or “the Company”) Parsortix CTCs used
RNS Number : 3458M CelLBxHealth PLC 15 July 2026 CelLBxHealth plc (“CelLBxHealth” or “the Company”) Q2 and
RNS Number : 1005J CelLBxHealth PLC 22 June 2026 For Immediate Release 22 June 2026 CelLBxHealth plc (“CelLBxHealth”
RNS Number : 7622D CelLBxHealth PLC 11 May 2026 The information contained within this announcement is deemed by the
RNS Number : 9962A CelLBxHealth PLC 20 April 2026 CelLBxHealth plc (“CelLBxHealth” or “the Company”) Research Collaboration